Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul;50(7):2560-2.
doi: 10.1128/AAC.00264-06.

Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible

Affiliations

Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible

Nadya Andini et al. Antimicrob Agents Chemother. 2006 Jul.

Abstract

Mycobacterium tuberculosis is intrinsically resistant to macrolides, a characteristic associated with expression of the erm(37) gene. This intrinsic resistance was found to be inducible with clarithromycin and the ketolide HMR3004. Furthermore, underlying the phenotypic induction was an increase in erm(37) mRNA levels.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
A. The level of erm(37) mRNA in M. tuberculosis 24 h after the addition of clarithromycin (CLR) (1, 2, 4, 8, 16, and 32 μg/ml). Relative expression represents mRNA levels from each experimental condition compared to those of organisms incubated in medium alone (0 μg/ml). B. The change in erm(37) mRNA levels in M. tuberculosis following addition of clarithromycin (2 μg/ml) relative to the mRNA levels at time zero. Inset—change in erm(37) mRNA levels (relative to time zero) of M. microti (micr) and M. tuberculosis (tb) incubated for 18 h with clarithromycin at 0.1 and 2 μg/ml, respectively. Each experimental condition was tested in triplicate.

References

    1. Buriankova, K., F. Doucet-Populaire, O. Dorson, A. Gondran, J. C. Ghnassia, J. Weiser, and J. L. Pernodet. 2004. Molecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complex. Antimicrob. Agents Chemother. 48:143-150. - PMC - PubMed
    1. Collins, L., and S. G. Franzblau. 1997. Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41:1004-1009. - PMC - PubMed
    1. Falzari, K., Z. Zhu, D. Pan, H. Liu, P. Hongmanee, and S. G. Franzblau. 2005. In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:1447-1454. - PMC - PubMed
    1. Hoffner, S. E., L. Gezelius, and B. Olsson-Liljequist. 1997. In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 40:885-888. - PubMed
    1. Luna-Herrera, J., V. Reddy, D. Daneluzzi, and P. Gangadharam. 1995. Antituberculosis activity of clarithromycin. Antimicrob. Agents Chemother. 39:2692-2695. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources